Patient-centeredness in the design of clinical trials

Value in Health

Volumn 17, Issue 4, 2014, Pages 471-475

  Mullins, C Daniel ^a   Vandigo, Joseph ^a   Zheng, Zhiyuan ^a,c   Wicks, Paul ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b PATIENTSLIKEME INC   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

adaptive; Bayesian; patient centered; pragmatic; trial design

Indexed keywords

BAYES THEOREM; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); HEALTH CARE PERSONNEL; HUMAN; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STUDY DESIGN;

ADAPTIVE; BAYESIAN; PATIENT-CENTERED; PRAGMATIC; TRIAL DESIGN;

BAYES THEOREM; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT PARTICIPATION; PATIENT-CENTERED CARE; RESEARCH DESIGN;

EID: 84903308331     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2014.02.012     Document Type: Article

References (18)

1. A New Definition of Patient Engagement: What is Engagement and Why Is It Important? Washington, DC: Center for Advancing Health, 2010. Available from: http://www.cfah.org/pdfs/CFAH-Engagement-Behavior-Framework-current.pdf. [Accessed October 4, 2012].
2. C.D. Mullins, A.M. Abdulhalim, and D.C. Lavallee Continuous patient engagement in comparative effectiveness research JAMA 307 2012 1587 1588
3. F.W. Verheggen, F.H. Nieman, E. Reerink, and G.J. Kok Patient satisfaction with clinical trial participation Int J Qual Health Care 10 1998 319 330
4. A. Sood, K. Prasad, and L. Chhatwani et al. Patients' attitudes and preferences about participation and recruitment strategies in clinical trials Mayo Clin Proc 84 2009 243 247
5. R.B. Gul, and P.A. Ali Clinical trials: the challenge of recruitment and retention of participants J Clin Nurs 19 2010 227 233
6. Patient-Centered Outcome Research Institute. Patient-Centered Outcomes Research. Washington, DC: Patient-Centered Outcome Research Institute, 2012. Available from: http://www.pcori.org/what-we-do/pcor/. [Accessed October 4, 2012].
7. K. Davis, S.C. Schoenbaum, and A.M. Audet A 2020 vision of patient-centered primary care J Gen Intern Med 20 2005 953 957
8. M. Roland, and D.J. Torgerson Understanding controlled trials: what are pragmatic trials? BMJ 316 1998 285
9. C. Nakamura, M. Bromberg, and S. Bhargava et al. Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatments J Med Internet Res 14 2012 e90
10. D.A. Berry Bayesian clinical trials Nat Rev Drug Discov 5 2006 27 36
11. D. Jones Adaptive trials receive boost Nat Rev Drug Discov 9 2010 345 348
12. Dragalin V. Adaptive designs: terminology and classification. Drug Inf J 2006;40:425-35. Available from: http://www.diahome.org/Tools/Content.aspx?type= eopdf&file=%2fproductfiles%2f8357%2fdiaj-14478%2Epdf. [Accessed October 4, 2012].
13. F. Collins From the NIH director: the importance of clinical trials NIH MedlinePlus 6 2011 2 3
14. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Guidance for the use of Bayesian statistics in medical device clinical trials - guidance for industry and FDA staff. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm071121.pdf. [Accessed November 7, 2013].
15. N. Marina, S. Bielack, and J. Whelan et al. International collaboration is feasible in trials for rare conditions: the EURAMOS experience Cancer Treat Res 152 2009 339 353
16. Kesselheim AS, and Gagne JJ Strategies for post-market surveillance of drugs for rare diseases Clin Pharmacol Therapeut 95 2014 265 268
17. S. Gupta, M.E. Faughnan, G.A. Tomlinson, and A.M. Bayoumi A framework for applying unfamiliar trial designs in studies of rare diseases J Clin Epidemiol 64 2011 1085 1094
18. Chow SC, Chang M. Adaptive design methods in clinical trials - a review. Orphanet J Rare Dis 2008;3:11. Available from: http://www.ojrd.com/content/3/1/ 11. [Accessed November 21, 2013].